The Law Library

Procedures for Transportation Workplace Drug and Alcohol Testing Programs - Addition of Certain Schedule II Drugs to the Department of Transportation (Us Department of Transportation Regulation) (Dot) (2018 Edition) The Law Library

Procedures for Transportation Workplace Drug and Alcohol Testing Programs - Addition of Certain Schedule II Drugs to the Department of Transportation (US Department of Transportation Regulation) (DOT) (2018 Edition) The Law Library presents the complete text of the Procedures for Transportation Workplace Drug and Alcohol Testing Programs - Addition of Certain Schedule II Drugs to the Department of Transportation (US Department of Transportation Regulation) (DOT) (2018 Edition). Updated as of May 29, 2018 The Department of Transportation is amending its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine as an initial test analyte; and remove methylenedioxyethylamphetamine as a confirmatory test analyte. The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U. S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This final rule clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and Consortium/Third Party Administrators to submit blind specimens. This book contains: - The complete text of the Procedures for Transportation Workplace Drug and Alcohol Testing Programs - Addition of Certain Schedule II Drugs to the Department of Transportation (US Department of Transportation Regulation) (DOT) (2018 Edition) - A table of contents with the page number of each section